Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

Table 3 Bacteriologic outcomes at the post-therapy/test of cure evaluation for the bacteriologically evaluable and bacteriologic modified intent to treat (bmITT) populations.

	Bacteriologically Evaluable Population		bmITT Population
Assessment	n (%)	95% CI*	n (%)	95% CI*
n	149		255
Satisfactory^†	137 (91.9)	87.5; 96.3	215 (84.3)	79.8; 88.8
Unsatisfactory^‡	12 (8.1)		40 (15.7)
Indeterminate	-		16 (6.3)

*Two-sided 95% confidence interval (CI).
^†Includes eradication, presumed eradication, and colonization.
^‡Includes reinfection, superinfection, recurrence, presumed persistence, and persistence.

ISSN: 1471-2334